Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Gepa-merz
2. L-ornithine-l-aspartate
3. Orn-asp
4. Ornithine Aspartate
5. Ornithylaspartate
1. 3230-94-2
2. L-ornithine-l-aspartate
3. L-ornithine L-aspartate Salt
4. Ornithine Aspartate
5. (s)-2,5-diaminopentanoic Acid Compound With (s)-2-aminosuccinic Acid (1:1)
6. Ornithine Aseparate
7. L-aspartic Acid, Compd. With L-ornithine (1:1)
8. (2s)-2-aminobutanedioic Acid;(2s)-2,5-diaminopentanoic Acid
9. Ornithine Aspartate (l-ornithine L-aspartate)
10. Mfcd00058084
11. Hepa-merz (tn)
12. Lola
13. Ruigan
14. Schembl361185
15. Dtxsid30883964
16. Bcp13530
17. Hy-a0282
18. Ornithine Aspartate [who-dd]
19. L-ornithine L-aspartate Salt, Powder
20. Akos015998595
21. L-ornithine-l-aspartate (salt)
22. Ornithine L-form Aspartate [mi]
23. As-12577
24. L-ornithine, L-aspartate (1:1)
25. Aspartic Acid Compd. With Ornithine
26. Cs-0019764
27. O0440
28. Ornithine, L-, L-aspartate (1:1)
29. D08303
30. D70545
31. A821231
32. Q-102756
33. Q27281401
34. (s)-2,5-diaminopentanoic Acid (s)-2-aminosuccinic Acid Salt
35. (s)-2,5-diaminopentanoicacidcompoundwith(s)-2-aminosuccinicacid(1:1)
| Molecular Weight | 265.26 g/mol |
|---|---|
| Molecular Formula | C9H19N3O6 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 7 |
| Exact Mass | 265.12738533 g/mol |
| Monoisotopic Mass | 265.12738533 g/mol |
| Topological Polar Surface Area | 190 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 228 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35044
Submission : 2020-08-19
Status : Inactive
Type : II
Anlon Healthcare manufactures high-quality Pharmaceutical Bulk Drugs & Intermediates compliant with FDA, PMDA, KFDA, cGMP & WHO-GMP.
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41004
Submission : 2024-12-23
Status : Active
Type : II

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF







FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35044
Submission : 2020-08-19
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41004
Submission : 2024-12-23
Status : Active
Type : II

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Anlon Healthcare manufactures high-quality Pharmaceutical Bulk Drugs & Intermediates compliant with FDA, PMDA, KFDA, cGMP & WHO-GMP.
About the Company : Anlon Healthcare is a research-focused pharmaceutical manufacturer based in Rajkot, specializing in bulk drugs and intermediates. The company’s products comply with international...
About the Company : Fuan Pharmaceutical (Group) Co., Ltd. was established on February 25, 2004. The company is located in Chongqing Changshou Economic and Technological Development Zone, covering an a...

About the Company : Hanways Chempharm Co., Limited, the former one is Hubei Hanways Pharchem CO.,Limited, set up in 2009 in Wuhan, China. We are engaged in supplying APIs, pharmaceutical intermediate...

About the Company : Sailong Pharmaceutical Group Co., Ltd. ("Salon Pharmaceutical" for short) was established in 2002. It is a high-tech enterprise integrating drug research and development, productio...

About the Company : Sarshika Pharmachem LLP is a manufacturer of high-quality pharmaceutical and nutraceutical ingredients. Our mission is to offer a reliable, locally-produced alternative to Chinese-...

About the Company : Shouyuan chemical (one of the leading chemicals supplier in China) specializes in manufacturing, supplying, and custom synsthesis latest chemicals. Our products cover all kinds of ...

About the Company : Benepure is a global research, manufacture and supplier of ingredients and their derivatives for healthcare industry. It owns strong research and development team, cutting-edge equ...

About the Company : Summit ingredient Co.,Ltd is a leading and rapidly growing company wh ich engages in the production, development, source and sale of botanical extracts . Summit located in Shaanxi ...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
HepaCure (L-Ornithine L-Aspartate) is a Other Small Molecule drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Acute-On-Chronic Liver Failure.
Lead Product(s): L-Ornithine L-aspartate,Inapplicable
Therapeutic Area: Hepatology (Liver, Pancreatic, Gall Bladder) Brand Name: HepaCure
Study Phase: Phase I/ Phase IIProduct Type: Amino Acid
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable August 14, 2023

Lead Product(s) : L-Ornithine L-aspartate,Inapplicable
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Phase I/ Phase II
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : HepaCure (L-Ornithine L-Aspartate) is a Other Small Molecule drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Acute-On-Chronic Liver Failure.
Product Name : HepaCure
Product Type : Amino Acid
Upfront Cash : Inapplicable
August 14, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
The strategic cooperation between the two parties marks the obtainment of Winhealth Pharma for the exclusive commercial rights of Hepa-Merz® (L-ornithine L-aspartate, an important product under Merz' product portfolio) in China.
Lead Product(s): L-Ornithine L-aspartate,Inapplicable
Therapeutic Area: Neurology Brand Name: Hepa-Merz
Study Phase: Approved FDFProduct Type: Amino Acid
Sponsor: Hong Kong Winhealth Pharma Group
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration March 08, 2021

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : L-Ornithine L-aspartate,Inapplicable
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Hong Kong Winhealth Pharma Group
Deal Size : Undisclosed
Deal Type : Collaboration
Winhealth Pharma and Merz Collaborate on Hepa-Merz® to benefit patients with liver disease in Chi...
Details : The strategic cooperation between the two parties marks the obtainment of Winhealth Pharma for the exclusive commercial rights of Hepa-Merz® (L-ornithine L-aspartate, an important product under Merz' product portfolio) in China.
Product Name : Hepa-Merz
Product Type : Amino Acid
Upfront Cash : Undisclosed
March 08, 2021

Details:
L-Ornithine L-Aspartate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hepatic Encephalopathy.
Lead Product(s): L-Ornithine L-aspartate,Inapplicable
Therapeutic Area: Neurology Brand Name: Undisclosed
Study Phase: Phase IVProduct Type: Amino Acid
Sponsor: Merz Pharma
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable January 01, 2010

Lead Product(s) : L-Ornithine L-aspartate,Inapplicable
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : Merz Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.
Details : L-Ornithine L-Aspartate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hepatic Encephalopathy.
Product Name : Undisclosed
Product Type : Amino Acid
Upfront Cash : Inapplicable
January 01, 2010

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Regulatory Info :
Registration Country : India
Brand Name : L-Ornithine L-aspartate
Dosage Form : Granules
Dosage Strength : 3G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 5MG/10ML
Packaging : Ampoule
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Ukraine
Brand Name : Larnamin
Dosage Form : Concentrate for Solution for Injection
Dosage Strength : 500MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Ukraine

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Ukraine
Brand Name : Larnamin
Dosage Form : Granules for Oral Solution
Dosage Strength :
Packaging : 3G/5G Sachet
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Ukraine

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Moldova
Brand Name : Larnamin
Dosage Form : Granule For Oral Solution
Dosage Strength :
Packaging :
Approval Date : 04-04-2024
Application Number :
Regulatory Info :
Registration Country : Moldova

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Moldova
Brand Name : Larnamin
Dosage Form : Granule For Oral Solution
Dosage Strength :
Packaging :
Approval Date : 04-04-2024
Application Number :
Regulatory Info :
Registration Country : Moldova

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Moldova
Brand Name : Larnamin
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength :
Packaging :
Approval Date : 27-06-2022
Application Number :
Regulatory Info :
Registration Country : Moldova

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Hepa-Merz
Dosage Form : Infusion Concentrate
Dosage Strength : 5g/10ml
Packaging :
Approval Date : 09/06/1982
Application Number : 42592
Regulatory Info : Allowed
Registration Country : Switzerland

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Hepa-Merz
Dosage Form : Granules
Dosage Strength : 3g
Packaging :
Approval Date : 10/03/1986
Application Number : 46430
Regulatory Info : Allowed
Registration Country : Switzerland

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Brand Name : L-Ornithine L-Aspartate
Dosage Form : Liquid Injection
Dosage Strength : 5GM/10ML
Packaging : 10 ML
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
32
PharmaCompass offers a list of L-Ornithine L-aspartate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right L-Ornithine L-aspartate manufacturer or L-Ornithine L-aspartate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred L-Ornithine L-aspartate manufacturer or L-Ornithine L-aspartate supplier.
PharmaCompass also assists you with knowing the L-Ornithine L-aspartate API Price utilized in the formulation of products. L-Ornithine L-aspartate API Price is not always fixed or binding as the L-Ornithine L-aspartate Price is obtained through a variety of data sources. The L-Ornithine L-aspartate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A L-Ornithin-L-aspartat; manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L-Ornithin-L-aspartat;, including repackagers and relabelers. The FDA regulates L-Ornithin-L-aspartat; manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L-Ornithin-L-aspartat; API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of L-Ornithin-L-aspartat; manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A L-Ornithin-L-aspartat; supplier is an individual or a company that provides L-Ornithin-L-aspartat; active pharmaceutical ingredient (API) or L-Ornithin-L-aspartat; finished formulations upon request. The L-Ornithin-L-aspartat; suppliers may include L-Ornithin-L-aspartat; API manufacturers, exporters, distributors and traders.
click here to find a list of L-Ornithin-L-aspartat; suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A L-Ornithin-L-aspartat; DMF (Drug Master File) is a document detailing the whole manufacturing process of L-Ornithin-L-aspartat; active pharmaceutical ingredient (API) in detail. Different forms of L-Ornithin-L-aspartat; DMFs exist exist since differing nations have different regulations, such as L-Ornithin-L-aspartat; USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A L-Ornithin-L-aspartat; DMF submitted to regulatory agencies in the US is known as a USDMF. L-Ornithin-L-aspartat; USDMF includes data on L-Ornithin-L-aspartat;'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The L-Ornithin-L-aspartat; USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of L-Ornithin-L-aspartat; suppliers with USDMF on PharmaCompass.
L-Ornithin-L-aspartat; Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of L-Ornithin-L-aspartat; GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right L-Ornithin-L-aspartat; GMP manufacturer or L-Ornithin-L-aspartat; GMP API supplier for your needs.
A L-Ornithin-L-aspartat; CoA (Certificate of Analysis) is a formal document that attests to L-Ornithin-L-aspartat;'s compliance with L-Ornithin-L-aspartat; specifications and serves as a tool for batch-level quality control.
L-Ornithin-L-aspartat; CoA mostly includes findings from lab analyses of a specific batch. For each L-Ornithin-L-aspartat; CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
L-Ornithin-L-aspartat; may be tested according to a variety of international standards, such as European Pharmacopoeia (L-Ornithin-L-aspartat; EP), L-Ornithin-L-aspartat; JP (Japanese Pharmacopeia) and the US Pharmacopoeia (L-Ornithin-L-aspartat; USP).